BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 23632814)

  • 1. Outcome and toxicity using helical tomotherapy for craniospinal irradiation in pediatric medulloblastoma.
    Lopez Guerra JL; Marrone I; Jaen J; Bruna M; Sole C; Sanchez-Reyes A; Rivin E; Ortiz MJ; Calvo F; Matute R
    Clin Transl Oncol; 2014 Jan; 16(1):96-101. PubMed ID: 23632814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Multi-institutional Comparative Analysis of Proton and Photon Therapy-Induced Hematologic Toxicity in Patients With Medulloblastoma.
    Liu KX; Ioakeim-Ioannidou M; Susko MS; Rao AD; Yeap BY; Snijders AM; Ladra MM; Vogel J; Zaslowe-Dude C; Marcus KJ; Yock TI; Grassberger C; Braunstein SE; Haas-Kogan DA; Terezakis SA; MacDonald SM
    Int J Radiat Oncol Biol Phys; 2021 Mar; 109(3):726-735. PubMed ID: 33243479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of acute hematological toxicity on treatment interruptions during cranio-spinal irradiation in medulloblastoma: a tertiary care institute experience.
    Kumar N; Miriyala R; Thakur P; Madan R; Salunke P; Yadav B; Gupta A
    J Neurooncol; 2017 Sep; 134(2):309-315. PubMed ID: 28577033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late toxicity following craniospinal radiation for early-stage medulloblastoma.
    Christopherson KM; Rotondo RL; Bradley JA; Pincus DW; Wynn TT; Fort JA; Morris CG; Mendenhall NP; Marcus RB; Indelicato DJ
    Acta Oncol; 2014 Apr; 53(4):471-80. PubMed ID: 24564687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute toxicity profile of craniospinal irradiation with intensity-modulated radiation therapy in children with medulloblastoma: A prospective analysis.
    Cox MC; Kusters JM; Gidding CE; Schieving JH; van Lindert EJ; Kaanders JH; Janssens GO
    Radiat Oncol; 2015 Nov; 10():241. PubMed ID: 26597178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical combinations of radiation dose and volume predict intelligence quotient and academic achievement scores after craniospinal irradiation in children with medulloblastoma.
    Merchant TE; Schreiber JE; Wu S; Lukose R; Xiong X; Gajjar A
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):554-61. PubMed ID: 25160611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Craniospinal irradiation using helical tomotherapy for central nervous system tumors.
    Schiopu SR; Habl G; Häfner M; Katayama S; Herfarth K; Debus J; Sterzing F
    J Radiat Res; 2017 Mar; 58(2):238-246. PubMed ID: 28096196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiosurgery or hypofractionated stereotactic radiotherapy after craniospinal irradiation in children and adults with medulloblastoma and ependymoma.
    Napieralska A; Brąclik I; Radwan M; Mandera M; Blamek S
    Childs Nerv Syst; 2019 Feb; 35(2):267-275. PubMed ID: 30515559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vulnerability of white matter to insult during childhood: evidence from patients treated for medulloblastoma.
    Moxon-Emre I; Bouffet E; Taylor MD; Laperriere N; Sharpe MB; Laughlin S; Bartels U; Scantlebury N; Law N; Malkin D; Skocic J; Richard L; Mabbott DJ
    J Neurosurg Pediatr; 2016 Jul; 18(1):29-40. PubMed ID: 27015518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study on the risks of radiogenic second cancers and cardiac mortality in a set of pediatric medulloblastoma patients treated with photon or proton craniospinal irradiation.
    Zhang R; Howell RM; Taddei PJ; Giebeler A; Mahajan A; Newhauser WD
    Radiother Oncol; 2014 Oct; 113(1):84-8. PubMed ID: 25128084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease control and ototoxicity using intensity-modulated radiation therapy tumor-bed boost for medulloblastoma.
    Polkinghorn WR; Dunkel IJ; Souweidane MM; Khakoo Y; Lyden DC; Gilheeney SW; Becher OJ; Budnick AS; Wolden SL
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e15-20. PubMed ID: 21481547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scoliosis in Children Treated With Photon Craniospinal Irradiation for Medulloblastoma.
    Paulino AC; Suzawa HS; Dreyer ZE; Hanania AN; Chintagumpala M; Okcu MF
    Int J Radiat Oncol Biol Phys; 2021 Mar; 109(3):712-717. PubMed ID: 33516438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of prophylactic granulocyte-colony stimulating factor (G-CSF) on acute hematological toxicity in medulloblastoma patients during craniospinal irradiation (CSI).
    Madan R; Kumar N; Gupta A; Gupta K; Salunke P; Khosla D; Yadav BS; Kapoor R
    Clin Neurol Neurosurg; 2020 Sep; 196():105975. PubMed ID: 32505868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of permanent alopecia in pediatric medulloblastoma patients treated with proton radiation.
    Min CH; Paganetti H; Winey BA; Adams J; MacDonald SM; Tarbell NJ; Yock TI
    Radiat Oncol; 2014 Nov; 9():220. PubMed ID: 25403752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton therapy for adult medulloblastoma: Acute toxicity and disease control outcomes.
    Liu IC; Holtzman AL; Rotondo RL; Indelicato DJ; Gururangan S; Cavaliere R; Carter B; Morris CG; Tavanaiepour D; Rutenberg MS
    J Neurooncol; 2021 Jul; 153(3):467-476. PubMed ID: 34105033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced-dose craniospinal irradiation is feasible for standard-risk adult medulloblastoma patients.
    Massimino M; Sunyach MP; Barretta F; Gandola L; Garegnani A; Pecori E; Spreafico F; Bonneville-Levard A; Meyronet D; Mottolese C; Boschetti L; Biassoni V; Schiavello E; Giussani C; Carrabba G; Diletto B; Pallotti F; Stefini R; Ferrari A; Terenziani M; Casanova M; Luksch R; Meazza C; Podda M; Chiaravalli S; Puma N; Bergamaschi L; Morosi C; Calareso G; Giangaspero F; Antonelli M; Buttarelli FR; Frappaz D
    J Neurooncol; 2020 Jul; 148(3):619-628. PubMed ID: 32567042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Craniospinal irradiation using helical tomotherapy: evaluation of acute toxicity and dose distribution.
    Sugie C; Shibamoto Y; Ayakawa S; Mimura M; Komai K; Ishii M; Miyamoto A; Oda K
    Technol Cancer Res Treat; 2011 Apr; 10(2):187-95. PubMed ID: 21381797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing the radiation therapy dose prescription for pediatric medulloblastoma: minimizing the life years lost attributable to failure to control the disease and late complication risk.
    Brodin NP; Vogelius IR; Björk-Eriksson T; Munck Af Rosenschöld P; Maraldo MV; Aznar MC; Specht L; Bentzen SM
    Acta Oncol; 2014 Apr; 53(4):462-70. PubMed ID: 24274390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical Modeling of Image-Guided Craniospinal Irradiation for Very-High-Risk Medulloblastoma.
    Smith SMC; Bianski BM; Orr BA; Harknett G; Onar-Thomas A; Gilbertson RJ; Merchant TE; Roussel MF; Tinkle CL
    Int J Radiat Oncol Biol Phys; 2019 Mar; 103(3):728-737. PubMed ID: 30366006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overall survival and secondary malignant neoplasms in children receiving passively scattered proton or photon craniospinal irradiation for medulloblastoma.
    Paulino AC; Ludmir EB; Grosshans DR; Su JM; McGovern SL; Okcu MF; McAleer MF; Baxter PA; Mahajan A; Chintagumpala MM
    Cancer; 2021 Oct; 127(20):3865-3871. PubMed ID: 34254296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.